ROSSARIBSERossari Biotech LtdMediumNeutral
Announced Thu, 21 May · 21:24 IST

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.

Strategic Transactions View source PDF

ROSSARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹522.00
prior close
₹520.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.1-0.4-0.6+3.1+3.5+2.9+0.2-0.4+0.7-1.9+5.6-4.8
Up moveDown movePending
AI summary

Rossari Biotech Ltd has completed the sale of office premises owned by its subsidiary Unitop Chemicals Private Limited located at Saki Naka, Mumbai. The transaction was concluded on May 21, 2026 for a consideration of Rs. 10.50 crore (including stamp duty). The buyers are Mr. Jitendra Hakaram Choudhary, Mrs. Sunita Jitendra Choudhary, and Mr. Bhrupal Jitendra Choudhary, who are unrelated to the promoter or promoter group. The transaction is not classified as a related party transaction and was conducted at arm's length.

Likely market impact

This is a routine real estate transaction by the company and does not indicate any strategic shift in business operations. The sale proceeds of Rs. 10.50 crore may provide liquidity but is unlikely to have a significant impact on the stock given the modest size relative to the company's scale.